Financials
Latest | F'cast | |
---|---|---|
Div Yield | 5.1% | 0.0% |
Div Cover | 0.5 | 1.7 |
Op Mrgn | 15.9% | 23.3% |
ROCE | 12.0% |
Latest | F'cast | |
---|---|---|
P/E | 37.9 | 10.2 |
PEG | n/a | 0.0 |
Pr/Revenue | 1.9 | 1.9 |
Pr/Book | 1.6 |
Latest | F'cast | |
---|---|---|
Revenue | 3.6% | -9.3% |
PBT | -47.8% | 133.6% |
EPS | -65.0% | 235.7% |
DPS | 4.0% | 3.8% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 108.56 | 10.05 | 124.10p | 13.4 | n/a | 0% | 53.00p | 3.2% |
30-Jun-21 | 118.21 | 25.09 | 155.60p | 14.7 | 0.6 | +25% | 63.00p | 2.8% |
30-Jun-22 | 122.21 | 29.55 | 174.10p | 12.8 | 1.1 | +12% | 71.00p | 3.2% |
30-Jun-23 | 123.78 | 22.24 | 114.70p | 18.8 | n/a | -34% | 75.00p | 3.5% |
30-Jun-24 | 128.26 | 11.62 | 40.10p | 48.6 | n/a | -65% | 78.00p | 4.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-25 | 116.36 | 27.14 | 134.62p | 11.3 | 0.0 | +236% | 80.99p | 0.0% |
30-Jun-26 | 123.14 | 29.32 | 143.03p | 10.6 | 1.7 | +6% | 84.76p | 0.0% |
30-Jun-27 | 129.35 | 32.83 | 156.99p | 9.7 | 1.0 | +10% | 88.65p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Form 8.3 - Care REIT plc | 28-Mar-2025 | 12:42 | RNS |
Form 8.3 - Assura plc | 28-Mar-2025 | 12:35 | RNS |
Block Listing Application | 28-Mar-2025 | 10:00 | RNS |
Brooks Macdonald's surges 28% | 15-Sep-2011 | The Scotsman |
Expansion plan which Brooks no contradiction pro... | 16-Sep-2010 | The Scotsman |
Stop press | 19-Jan-2006 | Times |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
18-Mar-25 | Buy | Katherine Jones | 1,469.69p | 1,224 | £17,988.96 |
Currency | UK Pounds |
Share Price | 1,520.00p |
Change Today | 35.00p |
% Change | 2.36 % |
52 Week High | 2,080.00 |
52 Week Low | 1,400.00 |
Volume | 68,150 |
Shares Issued | 16.38m |
Market Cap | £249.01m |
Beta | 0.01 |
RiskGrade | 164 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 4 |
Neutral | 1 |
Sell | 1 |
Strong Sell | 0 |
Total | 8 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 13-Mar-25 | 19-Sep-24 |
Paid | 11-Apr-25 | 01-Nov-24 |
Amount | 30.00p | 49.00p |
Time | Volume / Share Price |
16:35 | 10,000 @ 1,520.00p |
14:50 | 10,000 @ 1,485.00p |
16:35 | 533 @ 1,520.00p |
16:35 | 4,900 @ 1,520.00p |
16:35 | 431 @ 1,520.00p |
CEO | Andrea Montague |
Chair | Maarten Slendebroek |
You are here: research